Align Technology Stock Fundamentals
AFW Stock | EUR 181.90 5.20 2.94% |
Align Technology fundamentals help investors to digest information that contributes to Align Technology's financial success or failures. It also enables traders to predict the movement of Align Stock. The fundamental analysis module provides a way to measure Align Technology's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Align Technology stock.
Align |
Align Technology Company Current Valuation Analysis
Align Technology's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Align Technology Current Valuation | 13.59 B |
Most of Align Technology's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Align Technology is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Competition |
In accordance with the recently published financial statements, Align Technology has a Current Valuation of 13.59 B. This is 5.37% lower than that of the Healthcare sector and 9.4% higher than that of the Medical Devices industry. The current valuation for all Germany stocks is 18.24% higher than that of the company.
Align Technology Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Align Technology's current stock value. Our valuation model uses many indicators to compare Align Technology value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Align Technology competition to find correlations between indicators driving Align Technology's intrinsic value. More Info.Align Technology is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about 0.69 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Align Technology is roughly 1.45 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Align Technology's earnings, one of the primary drivers of an investment's value.Align Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Align Technology's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Align Technology could also be used in its relative valuation, which is a method of valuing Align Technology by comparing valuation metrics of similar companies.Align Technology is currently under evaluation in current valuation category among its peers.
Align Fundamentals
Return On Equity | 0.1 | |||
Return On Asset | 0.0691 | |||
Profit Margin | 0.1 % | |||
Operating Margin | 0.18 % | |||
Current Valuation | 13.59 B | |||
Shares Outstanding | 76.61 M | |||
Shares Owned By Insiders | 6.49 % | |||
Shares Owned By Institutions | 90.97 % | |||
Price To Earning | 36.83 X | |||
Price To Book | 4.09 X | |||
Price To Sales | 3.76 X | |||
Revenue | 3.73 B | |||
Gross Profit | 2.64 B | |||
EBITDA | 779.84 M | |||
Net Income | 361.57 M | |||
Cash And Equivalents | 720.92 M | |||
Cash Per Share | 9.02 X | |||
Total Debt | 59.14 M | |||
Debt To Equity | 4.30 % | |||
Current Ratio | 1.85 X | |||
Book Value Per Share | 46.45 X | |||
Cash Flow From Operations | 568.73 M | |||
Earnings Per Share | 4.42 X | |||
Price To Earnings To Growth | 10.68 X | |||
Target Price | 743.46 | |||
Number Of Employees | 10 | |||
Beta | 1.62 | |||
Market Capitalization | 22.27 B | |||
Total Asset | 5.95 B | |||
Net Asset | 5.95 B |
About Align Technology Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Align Technology's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Align Technology using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Align Technology based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Align Technology, Inc., a medical device company, designs, manufactures, and markets Invisalign clear aligners and iTero intraoral scanners and services for orthodontics, and restorative and aesthetic dentistry worldwide. The company was founded in 1997 and is headquartered in San Jose, California. ALIGN TECHNOLOGY operates under Medical Devices classification in Germany and is traded on Frankfurt Stock Exchange. It employs 11660 people.
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in Align Stock
When determining whether Align Technology offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Align Technology's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Align Technology Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Align Technology Stock:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Align Technology. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For more detail on how to invest in Align Stock please use our How to Invest in Align Technology guide.You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.